VEGF is the most prominent angiogenic molecule and has been shown to parallel tumor growth and metastasis in various cancer types [25] and is currently the most promising target for anti-angiogenic therapy in ovarian cancer [6-8]. The gene discussed is VEGFA; the disease is ovarian cancer.